Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

2.550
+0.0100.39%
Volume:17.80K
Turnover:44.96K
Market Cap:1.96B
PE:15.50
High:2.550
Open:2.530
Low:2.520
Close:2.540
52wk High:3.319
52wk Low:1.959
Shares:770.00M
Float Shares:421.34M
Volume Ratio:0.16
T/O Rate:0.00%
Dividend:0.71
Dividend Rate:27.96%
EPS(TTM):0.164
EPS(LYR):0.412
ROE:11.28%
ROA:5.13%
PB:2.22
PE(LYR):6.18

Loading ...

Singapore Shares Surge More Than 1% as DBS Books Record Total Income

MT Newswires
·
Apr 30

Tianjin Pharmaceuticals Da Ren Tang's Attributable Profit Jumps 13% in Q1; Shares Up 5%

MT Newswires
·
Apr 30

Stock Track | TJ DaRenTang USD Soars 3.12% Intraday on Strong Q1 Earnings and New Strategic Plan

Stock Track
·
Apr 30

Tianjin Pharmaceutical Da Ren Tang Board Clears Q1 FY2026 Results, Adopts 2026 Efficiency Plan and Ends Equity Custody Agreement

SGX Filings
·
Apr 29

Tianjin Pharmaceutical Da Ren Tang reviews 2025 targets, adopts new 2026 action plan

SGX Filings
·
Apr 29

Tianjin Pharma Da Ren Tang Q1 net profit rises to RMB423 million on stronger TCM sales

SGX Filings
·
Apr 29

Tianjin Pharmaceutical Da Ren Tang Group Proposes New Independent Director

SGX Filings
·
Apr 16

Tianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees

SGX Filings
·
Apr 02

Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%

MT Newswires
·
Mar 31

Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025

MT Newswires
·
Mar 31

Stock Track | TJ DaRenTang USD Soars 3.65% Intraday on Strong Profitability Metrics and New Shareholder Return Plan

Stock Track
·
Mar 31

Tianjin Pharmaceutical Da Ren Tang proposes S$589 million guarantees for affiliates

SGX Filings
·
Mar 30

Tianjin Pharmaceutical Da Ren Tang releases semi-annual risk report on group finance subsidiary

SGX Filings
·
Mar 30

Tianjin Pharmaceutical Da Ren Tang Appoints New Representative for A-Share Placement Oversight

SGX Filings
·
Mar 24